address1,address2,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,shortName,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,regularMarketChangePercent,regularMarketPrice,marketState,longName,trailingPegRatio
"8-2-337, Road No. 3",Banjara Hills,Hyderabad,500034,India,91 40 4900 2900,https://www.drreddys.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.",27811,"[{'maxAge': 1, 'name': 'Mr. Gunupati Venkateswara Prasad B.E.', 'age': 64, 'title': 'Co-Chairman, MD & Member of Management Council', 'yearBorn': 1960, 'fiscalYear': 2025, 'totalPay': 188340000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kallam Satish Reddy B.Tech., M.S.', 'age': 57, 'title': 'Chairman of the Board & Member of the Management Council', 'yearBorn': 1967, 'fiscalYear': 2025, 'totalPay': 118230000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Erez  Israeli M.B.A.', 'age': 56, 'title': 'CEO & Member of the Management Council', 'yearBorn': 1968, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mannam  Venkatanarasimham', 'age': 55, 'title': 'CFO & Member of the Management Council', 'yearBorn': 1969, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Krishna K. Venkatesh B.Pharma M.S.', 'age': 51, 'title': 'Global Head of Quality and Pharmacovigilance & Member of the Management Council', 'yearBorn': 1973, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Deepak  Sapra M.B.A.', 'age': 49, 'title': 'Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council', 'yearBorn': 1975, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Motupalli Venkata Ramana M.B.A.', 'age': 55, 'title': 'CEO of Branded Markets - India & Emerging Countries and Member of Management Council', 'yearBorn': 1969, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Archana  Bhaskar B.Sc., M.B.A.', 'age': 57, 'title': 'EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council', 'yearBorn': 1967, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sanjay  Sharma B.Tech.', 'age': 56, 'title': 'Executive VP, Global Head of Global Manufacturing & Member of Management Council', 'yearBorn': 1968, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Patrick  Aghanian B.A., M.B.A.', 'age': 59, 'title': 'Head of Generics, Europe & Consumer Health and Member of Management Council', 'yearBorn': 1965, 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}]",1767139200,[],86400,2,1326.1,1332.4,1318.2,1335.0,1326.1,1332.4,1318.2,1335.0,8.0,0.6,1752019200,0.118,0.61,0.386,19.558737,3.8626099,1843556,1843556,2269052,1687460,1687460,0.0,0.0,0,0,1103056470016,1020.0,1421.49,3.388442,1226.69,1242.8881,8.0,0.0060327277,INR,False,1095955316736,0.1737,594882220,832118976,0.30144,0.50479,832307008,400.705,3.307421,1743379200,1774915200,1743379200,0.219,56544002048,67.76,343.11,5:1,1730073600,3.367,12.336,0.10297847,0.094471335,8.0,1752105600,EQUITY,1325.3,1575.0,902.0,1277.9843,1249.0,2.68421,hold,38,57907998720,69.601,88840003584,46765998080,1.16,1.918,325535006720,13.87,390.822,0.10368,0.18534,190428004352,11920249856,46428000256,0.22,0.201,0.58497,0.27290002,0.20395,INR,DRREDDY.NS,en-US,US,Equity,Delayed Quote,True,HIGH,DR. REDDY S LABORATORIES,"[{'header': 'Dividend', 'message': 'DRREDDY.NS announced a cash dividend of 8.00 with an ex-date of Jul. 10, 2025', 'meta': {'eventType': 'DIVIDEND', 'dateEpochMs': 1752085800000, 'amount': '8.00'}}]",1750413598,NSI,finmb_881725,Asia/Kolkata,IST,19800000,in_market,False,False,820467900000,-0.79992676,1318.2 - 1335.0,NSE,2269052,305.30005,0.29931378,1020.0 - 1421.49,-96.18994,-0.06766839,10.297847,1746788340,1753441140,1753790400,1746799200,1746799200,True,67.76,343.11,67.94996,19.504059,98.61011,0.08038715,82.41199,0.066306844,15,15,2.7 - Hold,False,-0.060321752,1325.3,POSTPOST,Dr. Reddy's Laboratories Limited,
